Clinical Trial Update: Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality

View source ↗

Summary

A clinical trial evaluating a combined molecular breast imaging and breast tomosynthesis diagnostic modality has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer | Status: WITHDRAWN